Glen Eagle Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-110
| Closed | -$10.6K | – | 1000 |
|
|
2020
Q3 | $10.6K | Buy |
+110
| New | +$10.6K | ﹤0.01% | 586 |
|
|
2020
Q1 | – | Sell |
-65
| Closed | -$6.99K | – | 908 |
|
|
2019
Q4 | $6.99K | Buy |
+65
| New | +$6.99K | ﹤0.01% | 660 |
|
|
2018
Q1 | – | Sell |
-55
| Closed | -$4.27K | – | 700 |
|
|
2017
Q4 | $4.27K | Hold |
55
| – | – | ﹤0.01% | 527 |
|
|
2017
Q3 | $3.37K | Hold |
55
| – | – | ﹤0.01% | 552 |
|
|
2017
Q2 | $2.53K | Buy |
+55
| New | +$2.53K | ﹤0.01% | 527 |
|